Paolo Bodini
About
In The Last Decade
Paolo Bodini
21 papers receiving 434 citations
Peers
Comparison fields: 5 of 73
- Surgery 219
- Epidemiology 217
- Pulmonary and Respiratory Medicine 180
- Genetics 141
- Hepatology 81
Countries citing papers authored by Paolo Bodini
This map shows the geographic impact of Paolo Bodini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Bodini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Bodini more than expected).
Fields of papers citing papers by Paolo Bodini
This network shows the impact of papers produced by Paolo Bodini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Bodini. The network helps show where Paolo Bodini may publish in the future.
Co-authorship network of co-authors of Paolo Bodini
This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Bodini. A scholar is included among the top collaborators of Paolo Bodini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Bodini. Paolo Bodini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | OBESITY, BINGE EATING, OBSTRUCTION SLEEP APNEA AND PSYCHOPATHOLOGICAL FEA TURES | 5 |
| 3 | 24 | |
| 4 | 16 | |
| 5 | 40 | |
| 6 | 65 | |
| 7 | 2 | |
| 8 | [Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects]. | 1 |
| 9 | 75 | |
| 10 | [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients]. | 2 |
| 11 | [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature]. | 2 |
| 12 | Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study. | 28 |
| 13 | Non-alcoholic steatohepatitis. Report of five cases and review of the literature. | 8 |
| 14 | Probability of developing gallstones and related risk factors in 400 cirrhotics | 3 |
| 15 | 7 | |
| 16 | [Prevalence of infections of the ascitic fluid in 81 consecutive cirrhotic patients]. | 1 |
| 17 | Frequency of spontaneous bacterial peritonitis in 265 cirrhotics with ascites | 6 |
| 18 | 89 | |
| 19 | Cholelithiasis in cirrhosis: analysis of 500 cases. | 48 |
| 20 | 26 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.